[Federal Register Volume 60, Number 193 (Thursday, October 5, 1995)]
[Notices]
[Page 52198]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-24813]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meetings:

    Name of SEP: Central Immunology Lab for AIDS Vaccine Clinical 
Trials.
    Date: October 20, 1995.
    Time: 11:00 a.m.
    Place: Solar Bldg., Room 1A3, 6003 Executive Blvd., Bethesda, MD 
20892.
    Contact Person: Dr. Dianne E. Tingley, Scientific Review Admin., 
Solar Bldg., Room 4C07, 6003 Executive Boulevard, Bethesda, MD 
20892, (301) 496-0818.
    Purpose/Agenda: To evaluate contract proposals.

    Name of SEP: National Cooperative Drug Groups for the Treatment 
of HIV Infection.
    Date: October 30-31, 1995.
    Time: 8:30 a.m.
    Place: Holiday Inn Gaithersburg, Washingtonian Room, 2 
Montgomery Village Avenue, Gaithersburg, MD 20879, (301) 948-8900.
    Contact Person: Dr. Vassil Georgiev, Scientific Review Admin., 
Solar Bldg., Room 4C04, 6003 Executive Boulevard, Bethesda, MD 
20892, (301) 496-8206.
    Purpose/Agenda: To evaluate grant applications.

    Name of SEP: Research on Hantavirus and Other Emerging Viral 
Threats.
    Date: November 6-8, 1995.
    Time: 8:30 a.m.
    Place: Bethesda Ramada Hotel, 8400 Wisconsin Avenue, Bethesda, 
MD 20814, (301) 654-1000.
    Contact Person: Christopher Beisel, Scientific Review Admin., 
Solar Bldg., Room 4C03, 6003 Executive Boulevard, Bethesda, MD 
20892, (301) 402-4596.
    Purpose/Agenda: To evaluate grant applications.

    The meetings will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications 
and/or proposals and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and personal 
information concerning individuals associated with the application and/
or proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Nos. 93.855, 
Immunmology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 29, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-24813 Filed 10-4-95; 8:45 am]
BILLING CODE 4140-01-M